Male infertility
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Here, we show that targeted deletion of Rnf216 in mice results in disruption in spermatogenesis and male infertility.
|
30649198 |
2019 |
Klinefelter Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
We thus have identified that RNF216 regulates the migration of GnRH neuron by suppressing Beclin1 mediated autophagy, and indicated a potential contribution of autophagy to the hypogonadotropic hypogonadism.
|
30733708 |
2019 |
X-linked agammaglobulinemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Measured by TaqMan real-time polymerase chain reaction (PCR), meaningfully increased transcripts of SOCS1 and RNF216 were found in XLA peripheral blood mononuclear cells (PBMCs).
|
31185757 |
2019 |
Movement Disorders
|
0.010 |
Biomarker
|
group |
BEFREE |
RNF216) have recently been identified in patients suffering from Gordon Holmes syndrome (GHS), characterized by cognitive decline, dementia, and movement disorders.
|
27995769 |
2017 |
Mental deterioration
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
RNF216) have recently been identified in patients suffering from Gordon Holmes syndrome (GHS), characterized by cognitive decline, dementia, and movement disorders.
|
27995769 |
2017 |
Impaired cognition
|
0.010 |
Biomarker
|
disease |
BEFREE |
RNF216) have recently been identified in patients suffering from Gordon Holmes syndrome (GHS), characterized by cognitive decline, dementia, and movement disorders.
|
27995769 |
2017 |
Colorectal Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
This makes RNF216 as a potential biomarker and novel therapeutic target for inhibiting CRC development and progression.
|
27203674 |
2016 |
Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
RNF216 promoted CRC cell proliferation and migration in vitro and in vivo, largely by enhancing proteasomal degradation of BECN1, a key autophagy regulator and tumor suppressor.
|
27203674 |
2016 |
Malignant neoplasm of colon and/or rectum
|
0.010 |
Biomarker
|
disease |
BEFREE |
RNF216 contributes to proliferation and migration of colorectal cancer via suppressing BECN1-dependent autophagy.
|
27203674 |
2016 |
Cerebellar Ataxia
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Mutations in RNF216 have recently been found in families with Gordon Holmes syndrome, a condition defined by hypogonadotropic hypogonadism and cerebellar ataxia.
|
25841028 |
2015 |
Chorea
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Our study thus challenges the oligogenic inheritance model and emphasizes chorea as an essential clinical feature in RNF216-mediated neurodegeneration.
|
25841028 |
2015 |
Leukodystrophy, Hypomyelinating, with Hypodontia and Hypogonadotropic Hypogonadism
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
[1] classifying a patient with non-specific white matter abnormalities, cerebellar atrophy, hypogonadotropic hypogonadism and absent lower median incisors as 4H syndrome.He had mutations in RNF216.
|
26365775 |
2015 |
Carcinogenesis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
After thorough structural analysis, a novel fusion gene TSC2-RNF216 is identified, which may simultaneously disrupt tumor-suppressive pathways and activate tumorigenesis.
|
24690483 |
2014 |
Obesity
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Gene expression of RIPK3 and RNF216 in PBMC could identify those obese subjects, who will regain more weight after a successful initial weight loss.
|
19690434 |
2009 |
McCune-Albright Syndrome
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
A clinical diagnosis of MAS can be made when a patient is found to have at least two features of the classical triad (3).
|
17982384 |
2007 |
Ataxia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Dwarfism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dysarthria
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Gynecomastia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Infertility
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Leukodystrophy
|
0.100 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Muscle hypotonia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Nystagmus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Optic Atrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Speech Disorders
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|